A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumors

Molecular Imaging and Biology

Volumn 13, Issue 3, 2011, Pages 518-525

  Aide, Nicolas ^a,b,c,e   Kinross, Kathryn ^c   Beauregard, Jean Mathieu ^c   Neels, Oliver ^c   Potdevin, Titaina ^c   Roselt, Peter ^c   Dorow, Donna ^c   Cullinane, Carleen ^c   Hicks, Rodney J ^c,d  

^a Biology and Innovative Therapeutics for Ovarian Cancers group   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

Abdominal tumors; Contrast media; PET CT; Preclinical studies

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; IOHEXOL;

ABDOMINAL TUMOR; ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; IMAGE QUALITY; MOUSE; NONHUMAN; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ABDOMINAL NEOPLASMS; ANIMALS; ASCITES; CONTRAST MEDIA; DIDEOXYNUCLEOSIDES; FLUORODEOXYGLUCOSE F18; INJECTIONS, INTRAVENOUS; MICE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA; MUS;

EID: 79956191456     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0378-x     Document Type: Article

References (17)

1. RI Aqeilan JP Hagan HA Aqeilan F Pichiorri LY Fong CM Croce 2007 Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo Cancer Res 67 12 5606 5610 17575124 10.1158/0008-5472.CAN-07-1081 1:CAS:528:DC%2BD2sXmsFCqs7o%3D (Pubitemid 46984989)
2. T Fujishita Y Doi M Sonoshita, et al. 2004 Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice Br J Cancer 91 8 1571 1574 15467769 1:CAS:528:DC%2BD2cXotlCkurg%3D (Pubitemid 39486365)
3. S Kizaka-Kondoh S Itasaka L Zeng, et al. 2009 Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer Clin Cancer Res 15 3433 3441 19417024 10.1158/1078-0432.CCR-08-2267 1:CAS:528:DC%2BD1MXmtVKmu7Y%3D
4. XF Yi ST Yuan LJ Lu J Ding YJ Feng 2005 A clinically relevant orthotopic implantation nude mouse model of human epithelial ovarian cancer-based on consecutive observation Int J Gynecol Cancer 15 5 850 855 16174235 10.1111/j.1525-1438.2005.00147.x (Pubitemid 41783092)
5. P Choquet A Calon E Breton, et al. 2007 Multiple-contrast X-ray micro-CT visualization of colon malformations and tumours in situ in living mice C R Biol 330 11 821 827 17923376 10.1016/j.crvi.2007.08.002 (Pubitemid 47520472)
6. KC Graham SA Detombe LT MacKenzie, et al. 2008 Contrast-enhanced microcomputed tomography using intraperitoneal contrast injection for the assessment of tumor-burden in liver metastasis models Invest Radiol 43 7 488 495 18580331 10.1097/RLI.0b013e318172f5b5
7. I Willekens T Lahoutte N Buls, et al. 2009 Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC Mol Imaging Biol 11 2 128 135 19067081 10.1007/s11307-008-0186-8
8. M Almajdub M Nejjari G Poncet, et al. 2007 In vivo high-resolution X-ray microtomography for liver and spleen tumor assessment in mice Contrast Media Mol Imaging 2 2 88 93 17444558 10.1002/cmmi.130 1:CAS:528:DC%2BD2sXmt1Olt7c%3D (Pubitemid 46863625)
9. CE Suckow DB Stout 2008 MicroCT liver contrast agent enhancement over time, dose, and mouse strain Mol Imaging Biol 10 2 114 120 18204990 10.1007/s11307-007-0128-x
10. DM Dinulescu TA Ince BJ Quade SA Shafer D Crowley T Jacks 2005 Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer Nat Med 11 1 63 70 15619626 10.1038/nm1173 1:CAS:528:DC%2BD2MXptVSm (Pubitemid 40215839)
11. BJ Pichler HF Wehrl MS Judenhofer 2008 Latest advances in molecular imaging instrumentation J Nucl Med 49 Suppl 2 5S 23S 18523063 10.2967/jnumed.108.045880 (Pubitemid 351948034)
12. G Antoch W Jentzen LS Freudenberg, et al. 2003 Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging Invest Radiol 38 12 784 789 14627896 1:CAS:528:DC%2BD3sXptV2jtLg%3D (Pubitemid 37444951)
13. K Serdons A Verbruggen G Bormans 2008 The presence of ethanol in radiopharmaceutical injections J Nucl Med 49 12 2071 18997045 10.2967/jnumed.108.057026
14. C Cohade M Osman Y Nakamoto, et al. 2003 Initial experience with oral contrast in PET/CT: phantom and clinical studies J Nucl Med 44 3 412 416 12621008 (Pubitemid 39586018)
15. E Dizendorf TF Hany A Buck GK von Schulthess C Burger 2003 Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies J Nucl Med 44 5 732 738 12732674 (Pubitemid 39655207)
16. N Aide C Desmonts JM Beauregard, et al. 2010 High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications Eur J Nucl Med Mol Imaging 37 991 1001 20107792 10.1007/s00259-009-1352-1
17. D Denoyer I Greguric P Roselt, et al. 2010 High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance J Nucl Med 51 3 441 447 20150254 10.2967/jnumed.109.070060 1:CAS:528:DC%2BC3cXksVylsr0%3D